Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip

Giuliana Lo Cascio,1– 3 Alda Bazaj,1 Laura Trovato,2,4 Silvana Sanna,2,5 Stefano Andreoni,2,6 Elisabetta Blasi,2,7 Marco Conte,2,8 Paolo Fazii,2,9 Ester Oliva,10 Valentina Lepera,11 Gianluigi Lombardi,2,11 Claudio Farina2,10 1Clinical Microbiology and Virology Unit, Azienda Ospedaliera Universitaria...

Full description

Bibliographic Details
Main Authors: Lo Cascio G, Bazaj A, Trovato L, Sanna S, Andreoni S, Blasi E, Conte M, Fazii P, Oliva E, Lepera V, Lombardi G, Farina C
Format: Article
Language:English
Published: Dove Medical Press 2022-10-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/multicenter-italian-study-on-in-vitro-activities-of-isavuconazole-vori-peer-reviewed-fulltext-article-IDR
_version_ 1811181266724192256
author Lo Cascio G
Bazaj A
Trovato L
Sanna S
Andreoni S
Blasi E
Conte M
Fazii P
Oliva E
Lepera V
Lombardi G
Farina C
author_facet Lo Cascio G
Bazaj A
Trovato L
Sanna S
Andreoni S
Blasi E
Conte M
Fazii P
Oliva E
Lepera V
Lombardi G
Farina C
author_sort Lo Cascio G
collection DOAJ
description Giuliana Lo Cascio,1– 3 Alda Bazaj,1 Laura Trovato,2,4 Silvana Sanna,2,5 Stefano Andreoni,2,6 Elisabetta Blasi,2,7 Marco Conte,2,8 Paolo Fazii,2,9 Ester Oliva,10 Valentina Lepera,11 Gianluigi Lombardi,2,11 Claudio Farina2,10 1Clinical Microbiology and Virology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy; 2Medical Mycology Committee, Italian Society of Clinical Microbiologist, Milan, Italy; 3Clinical Microbiology and Virology Unit, Azienda USL, Piacenza, Italy; 4Clinical Microbiology, Azienda Ospedaliera Universitaria- Policlinico Vittorio Emanuele, Catania, Italy; 5Microbiology and Virology Unit, Azienda Ospedaliera Universitaria, Sassari, Italy; 6Microbiology and Virology Unit, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy; 7Clinical Microbiology, Azienda Ospedaliero-Universitaria, Policlinico di Modena, Modena, Italy; 8Microbiology and Virology Unit, Grande Ospedale Metropolitano Bianchi- Melacrino- Morelli, Reggio, Calabria, Italy; 9Clinical Microbiology and Virology P.O. Spirito Santo, Pescara, Italy; 10Clinical Microbiology and Virology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy; 11Clinical Microbiology, ASST Grande Ospedale Metropolitano Niguarda, Milan, ItalyCorrespondence: Giuliana Lo Cascio, Email g.locascio@ausl.pc.itAbstract: In this study the activity of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin against 224 clinical isolates of Aspergillus spp. originating from seven Italian hospitals, was comparatively evaluated with two commercial antifungal susceptibility tests (AST): SensititreTM YeastOneTM (SYO) and MIC Test Strip. More attention was focused on Isavuconazole activity, given the new introduction of the drug in widely distributed antifungal susceptibilities methods in the clinical microbiology lab. The minimum inhibitory concentrations of antifungal drug that can inhibit the growth of pathogen by 90% (MIC90) for Isavuconazole detected by SYO were 0.5, 1, 0.25, and 2 μg/mL for Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, and Aspergillus niger, respectively, whilst they were 0.25, 0.25, 0.5, and 0.75 μg/mL by MIC Test Strip. Essential agreement between the two tested methods for Isavuconazole is 70% for all the species tested, 75.7% for A. fumigatus, 45.2% for A. flavus, 90.6% for A. terreus, and 40% for A. niger. Although the tested strains do not express any phenotypic resistance, MIC results were quite different if tested with microdilution broth or gradient agar method. This is the first Italian multicenter report on Isavuconazole MIC obtained employing the widely used SensititreTM Yeast OneTM (SYO) and MIC Test Strip on clinical isolates of Aspergillus.Keywords: antifungal susceptibilities, Aspergillus Isavuconazole susceptibilities, Sensititre and MIC Test Strip
first_indexed 2024-04-11T09:14:38Z
format Article
id doaj.art-1c36f4a72dca45e0b121de4c8f6a5f91
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-04-11T09:14:38Z
publishDate 2022-10-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-1c36f4a72dca45e0b121de4c8f6a5f912022-12-22T04:32:23ZengDove Medical PressInfection and Drug Resistance1178-69732022-10-01Volume 155839584878736Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test StripLo Cascio GBazaj ATrovato LSanna SAndreoni SBlasi EConte MFazii POliva ELepera VLombardi GFarina CGiuliana Lo Cascio,1– 3 Alda Bazaj,1 Laura Trovato,2,4 Silvana Sanna,2,5 Stefano Andreoni,2,6 Elisabetta Blasi,2,7 Marco Conte,2,8 Paolo Fazii,2,9 Ester Oliva,10 Valentina Lepera,11 Gianluigi Lombardi,2,11 Claudio Farina2,10 1Clinical Microbiology and Virology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy; 2Medical Mycology Committee, Italian Society of Clinical Microbiologist, Milan, Italy; 3Clinical Microbiology and Virology Unit, Azienda USL, Piacenza, Italy; 4Clinical Microbiology, Azienda Ospedaliera Universitaria- Policlinico Vittorio Emanuele, Catania, Italy; 5Microbiology and Virology Unit, Azienda Ospedaliera Universitaria, Sassari, Italy; 6Microbiology and Virology Unit, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy; 7Clinical Microbiology, Azienda Ospedaliero-Universitaria, Policlinico di Modena, Modena, Italy; 8Microbiology and Virology Unit, Grande Ospedale Metropolitano Bianchi- Melacrino- Morelli, Reggio, Calabria, Italy; 9Clinical Microbiology and Virology P.O. Spirito Santo, Pescara, Italy; 10Clinical Microbiology and Virology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy; 11Clinical Microbiology, ASST Grande Ospedale Metropolitano Niguarda, Milan, ItalyCorrespondence: Giuliana Lo Cascio, Email g.locascio@ausl.pc.itAbstract: In this study the activity of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin against 224 clinical isolates of Aspergillus spp. originating from seven Italian hospitals, was comparatively evaluated with two commercial antifungal susceptibility tests (AST): SensititreTM YeastOneTM (SYO) and MIC Test Strip. More attention was focused on Isavuconazole activity, given the new introduction of the drug in widely distributed antifungal susceptibilities methods in the clinical microbiology lab. The minimum inhibitory concentrations of antifungal drug that can inhibit the growth of pathogen by 90% (MIC90) for Isavuconazole detected by SYO were 0.5, 1, 0.25, and 2 μg/mL for Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, and Aspergillus niger, respectively, whilst they were 0.25, 0.25, 0.5, and 0.75 μg/mL by MIC Test Strip. Essential agreement between the two tested methods for Isavuconazole is 70% for all the species tested, 75.7% for A. fumigatus, 45.2% for A. flavus, 90.6% for A. terreus, and 40% for A. niger. Although the tested strains do not express any phenotypic resistance, MIC results were quite different if tested with microdilution broth or gradient agar method. This is the first Italian multicenter report on Isavuconazole MIC obtained employing the widely used SensititreTM Yeast OneTM (SYO) and MIC Test Strip on clinical isolates of Aspergillus.Keywords: antifungal susceptibilities, Aspergillus Isavuconazole susceptibilities, Sensititre and MIC Test Striphttps://www.dovepress.com/multicenter-italian-study-on-in-vitro-activities-of-isavuconazole-vori-peer-reviewed-fulltext-article-IDRantifungal susceptibilitiesaspergillus isavuconazole susceptibilitiessensititre and mic test strip
spellingShingle Lo Cascio G
Bazaj A
Trovato L
Sanna S
Andreoni S
Blasi E
Conte M
Fazii P
Oliva E
Lepera V
Lombardi G
Farina C
Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
Infection and Drug Resistance
antifungal susceptibilities
aspergillus isavuconazole susceptibilities
sensititre and mic test strip
title Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
title_full Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
title_fullStr Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
title_full_unstemmed Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
title_short Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
title_sort multicenter italian study on ldquo in vitro activities rdquo of isavuconazole voriconazole amphotericin b and caspofungin for aspergillus species comparison between sensititretm yeastonetm and mic test strip
topic antifungal susceptibilities
aspergillus isavuconazole susceptibilities
sensititre and mic test strip
url https://www.dovepress.com/multicenter-italian-study-on-in-vitro-activities-of-isavuconazole-vori-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT locasciog multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT bazaja multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT trovatol multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT sannas multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT andreonis multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT blasie multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT contem multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT faziip multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT olivae multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT leperav multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT lombardig multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip
AT farinac multicenteritalianstudyonldquoinvitroactivitiesrdquoofisavuconazolevoriconazoleamphotericinbandcaspofunginforaspergillusspeciescomparisonbetweensensititretmyeastonetmandmicteststrip